Systematic review and meta‐analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. (September 2015)
- Record Type:
- Journal Article
- Title:
- Systematic review and meta‐analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. (September 2015)
- Main Title:
- Systematic review and meta‐analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy
- Authors:
- Memon, S.
Lynch, A. C.
Bressel, M.
Wise, A. G.
Heriot, A. G. - Abstract:
- <abstract abstract-type="main" id="codi12976-abs-0001"> <title>Abstract</title> <sec id="codi12976-sec-0001" sec-type="section"> <title>Aim</title> <p>Restaging imaging by MRI or endorectal ultrasound (ERUS) following neoadjuvant chemoradiotherapy is not routinely performed, but the assessment of response is becoming increasingly important to facilitate individualization of management.</p> </sec> <sec id="codi12976-sec-0002" sec-type="section"> <title>Method</title> <p>A search of the MEDLINE and Scopus databases was performed for studies that evaluated the accuracy of restaging of rectal cancer following neoadjuvant chemoradiotherapy with MRI or ERUS against the histopathological outcome. A systematic review of selected studies was performed. The methodological quality of studies that qualified for meta‐analysis was critically assessed to identify studies suitable for inclusion in the meta‐analysis.</p> </sec> <sec id="codi12976-sec-0003" sec-type="section"> <title>Results</title> <p>Sixty‐three articles were included in the systematic review. Twelve restaging MRI studies and 18 restaging ERUS studies were eligible for meta‐analysis of T‐stage restaging accuracy. Overall, ERUS T‐stage restaging accuracy (mean [95% CI]: 65% [56–72%]) was nonsignificantly higher than MRI T‐stage accuracy (52% [44–59%]). Restaging MRI is accurate at excluding circumferential resection margin involvement. Restaging MRI and ERUS were equivalent for prediction of nodal status: the accuracy of<abstract abstract-type="main" id="codi12976-abs-0001"> <title>Abstract</title> <sec id="codi12976-sec-0001" sec-type="section"> <title>Aim</title> <p>Restaging imaging by MRI or endorectal ultrasound (ERUS) following neoadjuvant chemoradiotherapy is not routinely performed, but the assessment of response is becoming increasingly important to facilitate individualization of management.</p> </sec> <sec id="codi12976-sec-0002" sec-type="section"> <title>Method</title> <p>A search of the MEDLINE and Scopus databases was performed for studies that evaluated the accuracy of restaging of rectal cancer following neoadjuvant chemoradiotherapy with MRI or ERUS against the histopathological outcome. A systematic review of selected studies was performed. The methodological quality of studies that qualified for meta‐analysis was critically assessed to identify studies suitable for inclusion in the meta‐analysis.</p> </sec> <sec id="codi12976-sec-0003" sec-type="section"> <title>Results</title> <p>Sixty‐three articles were included in the systematic review. Twelve restaging MRI studies and 18 restaging ERUS studies were eligible for meta‐analysis of T‐stage restaging accuracy. Overall, ERUS T‐stage restaging accuracy (mean [95% CI]: 65% [56–72%]) was nonsignificantly higher than MRI T‐stage accuracy (52% [44–59%]). Restaging MRI is accurate at excluding circumferential resection margin involvement. Restaging MRI and ERUS were equivalent for prediction of nodal status: the accuracy of both investigations was 72% with over‐staging and under‐staging occurring in 10–15%.</p> </sec> <sec id="codi12976-sec-0004" sec-type="section"> <title>Conclusion</title> <p>The heterogeneity amongst restaging studies is high, limiting conclusive findings regarding their accuracies. The accuracy of restaging imaging is different for different pathological T stages and highest for T3 tumours. Morphological assessment of T‐ or N‐stage by MRI or ERUS is currently not accurate or consistent enough for clinical application. Restaging MRI appears to have a role in excluding circumferential resection margin involvement.</p> </sec> </abstract> … (more)
- Is Part Of:
- Colorectal disease. Volume 17:Number 9(2015)
- Journal:
- Colorectal disease
- Issue:
- Volume 17:Number 9(2015)
- Issue Display:
- Volume 17, Issue 9 (2015)
- Year:
- 2015
- Volume:
- 17
- Issue:
- 9
- Issue Sort Value:
- 2015-0017-0009-0000
- Page Start:
- 748
- Page End:
- 761
- Publication Date:
- 2015-09
- Subjects:
- Colon (Anatomy) -- Diseases -- Periodicals
Rectum -- Diseases -- Periodicals
616.34 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cdi ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/codi.12976 ↗
- Languages:
- English
- ISSNs:
- 1462-8910
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3322.110000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3527.xml